Andrei V Gudkov

11PUBLICATIONS
95CO-AUTHORS
Haematological tumoursTissue engineeringMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 21, 2026
The Nicotinamide Salvage Pathway is a Metabolic Vulnerability of High-Risk MDS Stem Cells.

|Jun 03, 2026
Toll-like receptor 5 protects against murine lung fibrosis through reduced dysbiosis, and TLR5 deficiency is associated with human IPF.

|Jun 02, 2025
The cell-permeable iron chelator M606 inhibits MYCN-driven neuroblastoma via an E2F3-mediated response.

Ruby Pandher, Chengyuan Xue, Laura D Gamble

|Nov 09, 2024
Enhancing Anti-PD-1 Immunotherapy by Targeting MDSCs via Hepatic Arterial Infusion in Breast Cancer Liver Metastases.

Minhyung Kim, Colin A Powers, Daniel T Fisher

|Oct 23, 2023
Cancer Relevance of Circulating Antibodies Against LINE-1 Antigens in Humans.

Alexandra V Vylegzhanina, Ivan A Bespalov, Ksenia A Novototskaya-Vlasova

|Nov 02, 2022
Unsupervised learning of aging principles from longitudinal data.

Konstantin Avchaciov, Marina P Antoch, Ekaterina L Andrianova

Pageof 2

Frequent Collaborators

3 joint publications

Anatoli S Gleiberman

3 joint publications

Ekaterina L Andrianova

2 joint publications

Andrei L Osterman

1 joint publications

Timothy V Pyrkov